The Effect of Individual Education on the Participation of Relatives of Cancer Patients in General Health and Cancer Screenings: A One Group Pretest-Post Test Study

Year 2022, Volume: 12 Issue: 4, 988 - 998, 30.12.2022

Habibe Özçelik , Sebahat Gözüm , Hasan Şenol Coşkun

https://doi.org/10.33808/clinexphealthsci.1026570

Abstract

Objective: The aim of this study was to evaluate whether or not there were changes in the behaviors of relatives of cancer patients such as learning the warning signs of cancer, engaging in cancer prevention strategies, and participating in screenings after education sessions in the clinic. Methods: This one-group pretest-posttest study was conducted with 238 relatives in a medical oncology clinic in Antalya, Turkey. Individual education sessions were conducted as an intervention, banners were hung about cancer, and general health information on checkups in the form of leaflets were distributed to each relative regarding cancer screenings. Reminder messages were sent to individuals to participate in screenings one and two months after the first interview. The posttest data were collected by phone in the third month. Four questionnaires were prepared based on the literature and national cancer screening standards. The face validity of the tools was evaluated by three experts and 15 relatives who not included as participants. Results: The rate of having a mammography increased from 19.8% to 33.9%, rates of having the fecal occult blood test increased from 16.9% to 23.8%, and rates of having the HPV test increased from 43.5% to 49.6%. The rate of having blood pressure checks within the last 12 months increased from 75.8% to 83.1%, rates of blood cholesterol measurement increased from 68.5% to 79%, and rates of blood glucose measurement increased from 70.2% to 79%. Conclusion: Education provided to the relatives increased participation in screenings.

Keywords

relatives, individual education, cancer screening, health behaviours, cancer prevention

References

• [1] Canbak T, Acar A, Unal E. p53 gene therapy for hepatocellular carcinoma. Arch Clin Exp Med. 2017;1(2):29-30.
• [2] İnciser Paşalak Ş, Seven M. Genetic advances in oncology and the effects on nursing roles. Hemşirelikte Eğitim ve Araştırma Dergisi. 2017; 14(3):212-217. (Turkish)
• 3] National Comprehensive Cancer Network (NCCN). NCCN Guidelines Version 1. Genetic/Familial high-risk assesment: Breast and ovarian; 2015.
• [4] Saarimaki L, Tammela TL, Maattanen L, Taari K, Kujala PM, Raitanen J, Auvinen A. Family history in the Finnish prostate cancer screening trial. Int J Cancer. 2015;136(9):2172-2177.
• [5] Schwab FD, Kilic N, Huang DJ, Schmid SM, Vetter M, Schotzau A, Güth U. Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer. Arch Gynecol Obstet. 2015;291(6):1387-1394.
• [6] Tehranifar P, Wu HC, Shriver T, Cloud AJ, Terry MB. Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters. Am J Epidemiol. 2015;181(3):204-212.
• [7] Ministry of Health. Yearly of health statistics 2016 2017 [Available from: https://dosyasb.saglik.gov.tr/ Eklenti/13183,sy2016turkcepdf.pdf?0
• [8] Turkish Statistical Institute. Turkey Health Survey 2016 [Available from: www.tuik.gov.tr/PdfGetir.do?id=24573.
• [9] Ilgaz A, Gözüm S. Primary purpose in cancer screenings firstdegree relatives. DEUHYO ED 2014;7(4):345-353.
• [10] Kırca N, Tuzcu A, Gözüm S. Breast cancer screening behaviors of first degree relatives of women receiving breast cancer treatment and the affecting factors. Eur J Breast Health. 2018;14(1):23-28.
• [11] Koca D, Öztop I, Yılmaz U. Evaluation of changes in the attitudes and behaviors of relatives of lung cancer patients toward cancer prevention and screening. Indian J Cancer. 2013;50(3):233-238.
• [12] Koç S, Esin MN. Screening behaviors, health beliefs, and related factors of first-degree relatives of colorectal cancer patients with ongoing treatment in Turkey. Cancer Nurs. 2014;37(6):E51-60.
• [13] Seven M, Bagcivan G, Akyuz A, Bolukbas F. Women with family history of breast cancer: How much are they aware of their risk? J Cancer Educ. 2018;33(4):915-921.
• [14] Son KY, Park SM, Lee CH, Choi GJ, Lee D, Jo S, Lee SH, Cho B. Behavioral risk factors and use of preventive screening services among spousal caregivers of cancer patients. Support Care Cancer. 2011;19(7):919-927.
• [15] Amuta AO, Barry AE. Influence of family history of cancer on engagement in protective health behaviors. American Journal of Health Education. 2015;46:157-164.
• [16] Paalosalo-Harris K, Skirton H. Mixed method systematic review: the relationship between breast cancer risk perception and health-protective behaviour in women with family history of breast cancer. J Adv Nurs. 2017;73(4):760-774.
• [17] Hayran O. Research and statistical methods in health sciences. Istanbul: Nobel Tıp Kitabevleri. 2012.
• [18] Şahin NŞ, Üner BA, Aydın M, Akçan A, Gemalmaz A, Dişçigil G, Demirağ S, Başak O. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening in Aydın central region. Jour Turk Fam Phy. 2015;19(1):37-48.
• [19] Açıkgöz A, Çehreli R, Ellidokuz H. Women’s knowledge and attıtude about cancer and the behavıour for early dıagnosıs procedures. J DEU Med. 2011;25(3):145-154.
• [20] Karadağ Çaman Ö, Bilir N, Özcebe H. Are family history of cancer and perceived cancer risk associated with cancer preventive behaviors? Firat Med J. 2014;19(2):95-100.
• [21] Ministry of Health. National standards of breast, cervix and colorectal cancer screening program: The Ministry of Health 2017 [Available from: https://hsgm.saglik.gov.tr/tr/kansertarama-standartlari.
• [22] Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrea FA, D’Este C, Hill D, Barker D, Simmons J. A population-based cross-sectional study of colorectal cancer screening practices of firstdegree relatives of colorectal cancer patients. BMC Cancer. 2013;13(13):1-11.
• [23] Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Alber S, Crespi CM, Chang LC. Randomized trial to increase colorectal cancer screening in an ethnically diverse sample of first-degree relatives. Cancer. 2015;121(17):2951-2959.
• [24] Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, Watterson D, Fox L, Sergeant JC, Ingham S, Harvie MN, Wilson M, Beetles U, Buchan I, Brentnall AR, French DP, Cuzick J, Howell A. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer. 2016;114(9):1045-1052.
• [25] Rawl SM, Christy SM, Monahan PO, Ding Y, Krier C, Champion VL, Rex D. Tailored telephone counseling increases colorectal cancer screening. Health Educ Res. 2015;30(4):622-637.
• [26] Baysal HY, Gozum S. Effects of health beliefs about mammography and breast cancer and telephone reminders on re-screening in Turkey. Asian Pac J Cancer Prev. 2011;12(6):1445-1450.
• [27] Gültekin M, Özgül N, Olcayto E, Tuncer M. Level of knowledge among turkısh people for cancer and cancer risk factors. J Turk Soc Obstet Gynecol 2011;8(1):57-61.
• [28] Saylam Kurtipek G, Gökşin Cihan Ş, Ataseven A, Özer İ, Can Turhan Z. The knowledge, attitude and behaviours of women above 18 years old about genital warts, cervical cancer and human papilloma virus vaccination. Turk J Dermato. 2016;10:105-109.
• [29] Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15:100896.
• [30] Ministry of Health. Tobacco control process in Turkey. 2016 [Available from: https://www.havanikoru.org.tr/bendevarim/104-kategorisiz/213-turkiye-de-tutunle-mucadelesureci.html?contact_ajax=432.364.1525481479&ctajaxmodid=318?contact_ajax=358.779.1525481598&ctajax_ modid=318.
• [31] Anderson AS, Dunlop J, Gallant S, Macleod M, Miedzybrodzka Z, Mutrie N, O’Carroll RE, Stead M, Steele RJC, Taylor RS, Vinnicombe S, Berg J. Feasibility study to assess the impact of a lifestyle intervention (‘LivingWELL’) in people having an assessment of their family history of colorectal or breast cancer. BMJ Open. 2018;8(2):e019410.